Predictive and prognostic roles of ribonucleotide reductase M1 in resectable pancreatic adenocarcinoma. - Wikidata - awgldk - TriplyDB

Predictive and prognostic roles of ribonucleotide reductase M1 in resectable pancreatic adenocarcinoma.

Predictive and prognostic roles of ribonucleotide reductase M1 in resectable pancreatic adenocarcinoma.

http://www.wikidata.org/entity/Q43829586

about

MicroRNA-1468-5p inhibits glioma cell proliferation and induces cell cycle arrest by targeting RRM1.Clinical implications of ribonucleotide reductase subunit M1 in patients with pancreatic cancer who undergo curative resection followed by adjuvant chemotherapy with gemcitabine.Pancreatic biomarkers: could they be the answer?Nucleotide metabolism, oncogene-induced senescence and cancer.The CREB-binding protein inhibitor ICG-001 suppresses pancreatic cancer growth.Translational research in pancreatic ductal adenocarcinoma: current evidence and future concepts.Novel approaches in the management of pancreatic ductal adenocarcinoma: potential promises for the future.A Potent Chemotherapeutic Strategy with Eg5 Inhibitor against Gemcitabine Resistant Bladder Cancer.Fasting cycles potentiate the efficacy of gemcitabine treatment in in vitro and in vivo pancreatic cancer models.High expression of survivin is prognostic of shorter survival but not predictive of adjuvant gemcitabine benefit in patients with resected pancreatic adenocarcinoma.Just getting into cells is not enough: mechanisms underlying 4-(N)-stearoyl gemcitabine solid lipid nanoparticle's ability to overcome gemcitabine resistance caused by RRM1 overexpression.Development of a metabolites risk score for one-year mortality risk prediction in pancreatic adenocarcinoma patients.Sclareolide enhances gemcitabine‑induced cell death through mediating the NICD and Gli1 pathways in gemcitabine‑resistant human pancreatic cancer.Do hENT1 and RRM1 predict the clinical benefit of gemcitabine in pancreatic cancer?Precision Medicine and Pancreatic Cancer: A Gemcitabine Pathway Approach.TGF-β-induced stromal CYR61 promotes resistance to gemcitabine in pancreatic ductal adenocarcinoma through downregulation of the nucleoside transporters hENT1 and hCNT3.Overcoming tumor cell chemoresistance using nanoparticles: lysosomes are beneficial for (stearoyl) gemcitabine-incorporated solid lipid nanoparticles.Effect of ribonucleotide reductase M1 expression on overall survival in patients with pancreatic cancer receiving gemcitabine chemotherapy: A literature-based meta-analysis.Overexpression of ribonucleotide reductase subunit M1 protein predicts shorter survival in metastatic bladder cancer patients treated with gemcitabine-containing combination chemotherapy.Intratumoural expression of deoxycytidylate deaminase or ribonuceotide reductase subunit M1 expression are not related to survival in patients with resected pancreatic cancer given adjuvant chemotherapy.RNA expression of genes involved in cytarabine metabolism and transport predicts cytarabine response in acute myeloid leukemia.

P2860

Q33622651-5D434733-6A7E-4E2B-8290-76F634870268 Q33684978-54B8B5FF-CF81-4364-81E1-75B97A3223AC Q33801371-CC9378FF-8FFC-46AC-B6F4-DD5ECA160837 Q33969333-A6B62DFA-9D56-4239-91E3-05ACC1AD9265 Q34041619-0F46C76C-8E89-4AD1-8234-16D6AA8E0EF0 Q34067863-6E45EF9B-5B69-42B6-B3DA-047ACC77BE10 Q35604577-0E986652-4698-4D9E-9231-A12B338CD196 Q35866655-17B669BC-A4D3-4FE8-851E-CD4BE5DF02FA Q36210934-0B8C8891-C70F-4A0C-8C8D-B4B0B308BC95 Q36796262-943DF84D-73D2-44BF-92BB-B1DFCA695E70 Q36931187-37C105CA-CAC9-4B16-A8FA-E0ADCE51A880 Q36962474-07FFC6A2-C555-4915-82D3-7653494CC07A Q37720259-2E7D816C-FE6C-4079-AF52-CA284D43AFFB Q38125770-C88E8959-E43E-4E79-9689-B4710D33E5A8 Q39283216-E653D038-C068-4772-B226-C91446067F2F Q40590883-84575776-118F-4774-860D-6A55DAE648DE Q49387560-2E09C32E-F1BC-460A-985C-D62974E85F4D Q50040885-07F4E35D-C6BB-4489-8106-F33DBED22B43 Q51206876-028F346D-0571-4141-B7A2-722C3F456519 Q52663568-1A6CDD45-E407-40A2-8249-36AFE6E96CB3 Q55056167-FE1094C8-5385-48D7-B197-408C72818CF8

P2860

Predictive and prognostic roles of ribonucleotide reductase M1 in resectable pancreatic adenocarcinoma.

http://www.wikidata.org/entity/Q43829586

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

Predictive and prognostic role ...... ble pancreatic adenocarcinoma.

@en

Predictive and prognostic role ...... ble pancreatic adenocarcinoma.

@nl

type

label

Predictive and prognostic role ...... ble pancreatic adenocarcinoma.

@en

Predictive and prognostic role ...... ble pancreatic adenocarcinoma.

@nl

prefLabel

Predictive and prognostic role ...... ble pancreatic adenocarcinoma.

@en

Predictive and prognostic role ...... ble pancreatic adenocarcinoma.

@nl

P1433

Q43829586-4DD94224-D6DB-4BA5-B891-79F7AA7CE479

P1476

Q43829586-13FC94E9-F259-4363-9F73-ABACDADB4B72

P2093

Q43829586-022E4C6E-4D02-4C3F-A481-AE0E236B19EF

Q43829586-0C146C1A-8FCF-4183-82B5-1045D1E0A9F3

Q43829586-3062CFBE-D520-41EC-A5D4-81F97F2DE9BA

Q43829586-583B9BAC-5C04-4BBC-8B9A-E4159458D188

Q43829586-E9E9DFDC-F0E5-45AA-A728-C74B9D0DDB0F

Q43829586-F875B7DB-B584-4CB4-A5C5-E77B8BAA8D48

P2860

Q43829586-1468430F-A43D-4CD5-B4AE-8362558BF891

Q43829586-1710E568-644F-40B7-9E2E-DE501A6494EA

Q43829586-283E6C25-50E9-4A09-9026-7AD9900A2BBB

Q43829586-2D34A89A-92C0-433A-B143-DCD186980C86

Q43829586-312615ED-45CE-4E11-A913-EBC686A944D8

Q43829586-3C1D30FA-F74B-4C35-AB38-4FF8FF4DC2AE

Q43829586-46A6AB9B-1EC7-4789-A16F-4D3B1A7B6CF9

Q43829586-4EAA2939-8B49-40FE-BAF8-BF9DC438749E

Q43829586-4ED8ADE2-33C5-4C77-8C86-48505B6153D1

Q43829586-57F7DFFB-FAE1-4017-A988-2F5AC6F5D2A7

P304

Q43829586-378F059D-464C-4952-9361-12C99AE22097

P31

Q43829586-278B8040-5CD4-4B6A-A375-B01728FF5486

P356

Q43829586-DF05D36D-47BB-45BD-B74C-153C94D714C8

P407

Q43829586-19803836-1885-4F7C-AAFC-70107819E0AF

P433

Q43829586-885FCB3B-D9C1-47D6-BF84-D8832DF6B136

P478

Q43829586-6D47CDD3-3717-494F-8A57-6FD97916F3C4

P50

Q43829586-759F9549-3C35-4F9E-BD23-5E3CF4D6AE88

P577

Q43829586-D42BA3AD-3753-474C-B0A2-958838B6373D

P5875

Q43829586-D68F7F76-13E3-4772-9E58-DC35CBFA7D3E

P698

Q43829586-9D6C5710-D8FC-4050-81CF-0486D44FD9E4

P921

Q43829586-5BCF8F55-4E50-4D82-A60C-079C909D473A

P356

P1433

P1476

Predictive and prognostic role ...... able pancreatic adenocarcinoma

@en

P2093

John Jiang

http://www.w3.org/2001/XMLSchema#string

Richard Kim

http://www.w3.org/2001/XMLSchema#string

Wei Jiang

http://www.w3.org/2001/XMLSchema#string

Xiaobo Liu

http://www.w3.org/2001/XMLSchema#string

Xiuli Liu

http://www.w3.org/2001/XMLSchema#string

Yixin Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Pancreatic cancer

Gemcitabine chemoresistance and molecular markers associated with gemcitabine transport and metabolism in human pancreatic cancer cells

Fluorouracil-based chemoradiation with either gemcitabine or fluorouracil chemotherapy after resection of pancreatic adenocarcinoma: 5-year analysis of the U.S. Intergroup/RTOG 9704 phase III trial.

Transcription analysis of human equilibrative nucleoside transporter-1 predicts survival in pancreas cancer patients treated with gemcitabine.

Gene expression levels as predictive markers of outcome in pancreatic cancer after gemcitabine-based adjuvant chemotherapy.

RRM1-induced metastasis suppression through PTEN-regulated pathways.

Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators.

Gemcitabine metabolic and transporter gene polymorphisms are associated with drug toxicity and efficacy in patients with locally advanced pancreatic cancer.

Empiric comparison of multivariate analytic techniques: advantages and disadvantages of recursive partitioning analysis.

Experiments to determine whether recursive partitioning (CART) or an artificial neural network overcomes theoretical limitations of Cox proportional hazards regression.

P304

173-181

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CNCR.27715

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

119

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-06-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

228071327

http://www.w3.org/2001/XMLSchema#string

P698

22736490

http://www.w3.org/2001/XMLSchema#string

P921